Planned option exercise and vesting share sales for BRZE (NASDAQ: BRZE)

Rhea-AI Filing Summary

BRZE: A broker-dealer submitted a Form 144 reporting proposed sales of Common Stock tied to option exercises and equity vesting.

The filing lists 26,425 shares from an exercise of options on 06/01/2026, 5,638 shares from Performance Stock Units and 4,859 shares from restricted stock vesting on 05/15/2026. The excerpt shows a prior sale of 35,000 shares by Susan M. Wiseman on 04/09/2026 for $710,090.50. Shares outstanding were 112,631,669 as of 06/01/2026.

Insights

Equity Issuance Specialist

Forms show routine insider-related sales tied to exercises and vesting.

The filing lists specific share lots: 26,425 from option exercise on 06/01/2026, 5,638 PSUs and 4,859 restricted shares vesting on 05/15/2026. These are administrative notices of proposed sales, not company-initiated offerings.

Cash-flow treatment and plan details are not included in the excerpt; subsequent broker reports or settlement filings would show actual disposition and proceeds.

Securities Compliance Analyst

Form 144 primarily notifies the market of intended resale methods tied to compensation events.

The document names a broker and shows a prior reported sale by Susan M. Wiseman: 35,000 shares sold on 04/09/2026 for $710,090.50. The listed actions are exercise/vesting events, common in post-vesting liquidity.

Timing and methods of any future resale depend on holder decisions and market filings; the filing itself does not specify distribution mechanics beyond the transaction labels shown.

Key Figures

Option exercise shares: 26,425 shares Performance Stock Units: 5,638 shares Restricted stock vesting: 4,859 shares +2 more

5 metrics

Option exercise shares 26,425 shares exercise of options on <date>06/01/2026</date>

Performance Stock Units 5,638 shares PSUs vesting on <date>05/15/2026</date>

Restricted stock vesting 4,859 shares vesting under a registered plan on <date>05/15/2026</date>

Prior insider sale 35,000 shares sold by Susan M. Wiseman on <date>04/09/2026</date> for <money>$710,090.50</money>

Shares outstanding 112,631,669 as of <date>06/01/2026</date>

Key Terms

Form 144, Performance Stock Units, restricted stock vesting

3 terms

Form 144 regulatory

"submitted a Form 144 reporting proposed sales of Common Stock"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Performance Stock Units financial

"Performance Stock Units | Issuer | | | 5638 | 05/15/2026"

Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.

restricted stock vesting financial

"Restricted stock vesting under a registered plan | Issuer | | | 4859 | 05/15/2026"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

FAQ

What does BRZE's Form 144 report?

It reports proposed sales of Common Stock tied to equity events. The filing lists 26,425 shares from an option exercise and additional shares from PSU vesting and restricted stock on specific dates.

How many shares were sold recently by an insider of BRZE?

The excerpt shows Susan M. Wiseman sold 35,000 shares on 04/09/2026 for $710,090.50. This is reported as a prior sale in the Form 144 excerpt.

Are the listed shares already transferred to the market?

The filing lists proposed sales tied to exercise and vesting; it does not confirm settlement. Actual dispositions and timing depend on subsequent broker/market activity and filings.

What equity events generated the shares listed in the filing?

The shares arise from an exercise of options (26,425 shares), Performance Stock Units (5,638), and restricted stock vesting (4,859) on the dates shown.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/01/2026 - 04:23 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001889752
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	BRAZE, INC.
SEC File Number	001-41065
Address of Issuer	63 Madison Building 28 East 28th Street, Floor 12 New York NEW YORK 10016
Phone	609-964-0585
Name of Person for Whose Account the Securities are To Be Sold	SUSAN M WISEMAN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	36922	1031028.39	112631669	06/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/01/2026	Exercise of options under a registered plan	Issuer			26425	06/01/2026	Not Applicable
Common	05/15/2026	Performance Stock Units	Issuer			5638	05/15/2026	Not Applicable
Common	05/15/2026	Restricted stock vesting under a registered plan	Issuer			4859	05/15/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
SUSAN M WISEMAN 63 Madison Building 28 East 28th Street, Floor 12 New York NY 10016	Common	04/09/2026	35000	710090.50

144: Remarks and Signature

Remarks
Date of Notice	06/01/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Susan Maiers Wiseman
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)